LG-1231

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLG-1231

Drug Alias NameLG-1231

ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionHepatitis C virus E2 glycoprotein modulatorsEnvelope glycoprotein modulators

TargetsHepatitis C virus E2 glycoproteinEnvelope glycoprotein

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesLentigen Technology Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLentigen Technology Inc

Active IndicationsN/A

Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A